Patented Microbial Consortium for Crop Yield Enhancement
A seven-strain microbial seed coating held as personal IP by a single researcher was incorporated, re-channelled through state agriculture procurement, and won two international agricultural grants.
- Origin
- ICAR research station, Punjab; founding scientist on institutional sabbatical, no business co-founder at engagement
- Founded
- 2020
- Core Innovation
- Seven-strain microbial consortium (nitrogen-fixing bacteria, phosphate-solubilising fungi, mycorrhizal agents) as seed coating and soil drench. Trial data: 23–31% yield increase across wheat, maize, soybean; 40% reduction in synthetic fertiliser requirement.
- Capital Outcome
- ₹4.70 Crore: Bill & Melinda Gates Foundation Agricultural Development Programme and EU Horizon Europe Cluster 6
Diagnostic findings at engagement
- The patent on the strain combination and formulation method was held in the name of the individual founding scientist, not by any registered legal entity. No company had been incorporated.
- Trial results were published across three peer-reviewed agronomy journals but had never been repackaged for a commercial or grant-funding audience; the only existing document was the academic manuscript itself.
- A prior application to the Department of Biotechnology's BioNEST programme had been rejected at the screening stage for an incomplete commercialisation plan.
- No structured understanding existed of the Gates Foundation's Agricultural Development programme architecture, its funding priorities, or its application requirements.
- The founder's stated go-to-market plan was direct sale to individual farmers: a channel strategy inconsistent with both production capacity and the cost of farmer-level customer acquisition in rural India.
Service interventions applied
Business Structure
Incorporated a private limited company. Executed an intellectual property assignment deed transferring the patent from the individual scientist to the new corporate entity, with founder shareholding structured under a four-year vesting schedule to preserve future equity fundraising eligibility.
Grant Narrative: Gates Foundation
Aligned the application with the Foundation's Smallholder Productivity focus area. Quantified the farmer-level economic case at ₹4,200 in annual input cost saving per acre, benchmarked against the Foundation's published cost-effectiveness thresholds for agricultural interventions targeting sub-$2-per-day smallholders.
Grant Narrative: EU Horizon Europe
Positioned the application under Cluster 6 (Food, Bioeconomy, Natural Resources, Agriculture and Environment). Structured an EU-India research collaboration with a European soil microbiome research partner to satisfy Horizon's international collaboration eligibility criterion, and connected the application's impact to the EU Farm to Fork strategy's 50% pesticide reduction target.
Go-to-Market Strategy
Replaced the direct-to-farmer model with a B2B2C structure routed through State Agriculture Departments, Farmer Producer Organisations, and Krishi Vigyan Kendras. Mapped procurement budgets across 22 state agriculture departments with active bio-input procurement allocations totalling approximately ₹2,400 Crore annually.
Financial Model Construction
Modelled production scale-up from existing laboratory capacity of 200 kilograms per month to a 24-month target of 5 metric tons per month, with gross margin analysis at three price points corresponding to government procurement, agri-input distributor, and premium direct-to-consumer organic farming channels.
Pitch Materials Reconstruction
Converted a 38-slide academic presentation built around journal citations into a 14-slide investor and grant-audience deck. Journal references were relocated to an appendix; the narrative opening changed from microorganism taxonomy to documented farmer income impact.
Observation: Intellectual Property Ownership
At engagement, the patent was held personally by the founding scientist rather than by a corporate entity: a structural condition common among researcher-led ventures spun out of public institutions. Both the Gates Foundation and EU Horizon Europe require that intellectual property generated or deployed under a funded project be held by a registered legal entity with a documented commercialisation pathway. Resolving this through incorporation and a formal assignment deed preceded all subsequent grant work and was completed within three weeks of engagement.
Position at engagement vs. position at close
Swipe the table sideways to compare.
| Dimension | At engagement | At close |
|---|---|---|
| Legal Entity Status | None; IP held by individual | Private limited company; IP assigned with vesting |
| Go-to-Market Channel | Direct-to-farmer | B2B2C via state agriculture departments and FPOs |
| Grant Applications | 1 rejected (DBT BioNEST) | 2 awarded (Gates Foundation, EU Horizon) |
| Capital Secured | ₹0 | ₹4.70 Crore |